Εμφανίζονται 1 - 20 Αποτελέσματα από 32 για την αναζήτηση 'Gerd R Burmester', χρόνος αναζήτησης: 0,07δλ Περιορισμός αποτελεσμάτων
  1. 1
    Celebrating the global impact of rheumatology research: preface to the Viewpoint Article—‘What are the hot topics in Japanese rheumatology?—Go above and beyond’ by Yoshiya Tanaka, Japan

    Celebrating the global impact of rheumatology research: preface to the Viewpoint Article—‘What are the hot topics in Japanese rheumatology?—Go above and beyond’ by Yoshiya Tanaka,... ανά Gerd R Burmester

    Έκδοση 2023-03-01
    Λήψη πλήρους κειμένου
    Άρθρο
  2. 2
    Axial psoratic arthritis: are you a lumper or a splitter?

    Axial psoratic arthritis: are you a lumper or a splitter? ανά Gerd R Burmester, Laura C Coates

    Έκδοση 2023-04-01
    Λήψη πλήρους κειμένου
    Άρθρο
  3. 3
    Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, Germany.

    Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, Germany. ανά Ulrich Thiem, Rainer Lamsfuß, Sven Günther, Jochen Schumacher, Christian Bäker, Heinz G Endres, Josef Zacher, Gerd R Burmester, Ludger Pientka

    Έκδοση 2013-01-01
    Λήψη πλήρους κειμένου
    Άρθρο
  4. 4
    Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study

    Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study ανά Daniel E Furst, Paul Emery, Gerd R Burmester, Vivian P Bykerk, Bernard G Combe, Michael A Maldonado, Tom WJ Huizinga

    Έκδοση 2019-06-01
    Λήψη πλήρους κειμένου
    Άρθρο
  5. 5
    Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review

    Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review ανά Michael Kreuter, Marco Matucci-Cerinic, Yannick Allanore, Dinesh Khanna, Paul Emery, Gerd R Burmester, Janet Pope, Philippe Dieude, Eric L. Matteson

    Έκδοση 2023-07-01
    Λήψη πλήρους κειμένου
    Άρθρο
  6. 6
    Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study

    Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study ανά Sandra Hermann, Gerd R Burmester, Sarah Ohrndorf, Marina Backhaus, Paula Hoff, Jens Klotsche, Anne-Marie Glimm, Schahrasad Lisa Ridha Ali, Gabriela Schmittat

    Έκδοση 2021-08-01
    Λήψη πλήρους κειμένου
    Άρθρο
  7. 7
    Performance of Deauville Criteria in <sup>[18F]</sup>FDG-PET/CT Diagnostics of Giant Cell Arteritis

    Performance of Deauville Criteria in <sup>[18F]</sup>FDG-PET/CT Diagnostics of Giant Cell Arteritis ανά Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Walter-Rittel, Julian Rogasch, Robert Biesen, Gerd R. Burmester, Holger Amthauer, Udo Schneider, Christian Furth

    Έκδοση 2023-01-01
    Λήψη πλήρους κειμένου
    Άρθρο
  8. 8
    Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials

    Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials ανά Gerd R. Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F. Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S. Gensler

    Έκδοση 2024-04-01
    Λήψη πλήρους κειμένου
    Άρθρο
  9. 9
    Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

    Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials ανά Mark C. Genovese, Gerd R. Burmester, Owen Hagino, Karthinathan Thangavelu, Melitza Iglesias-Rodriguez, Gregory St John, Miguel A. González-Gay, Thomas Mandrup-Poulsen, Roy Fleischmann

    Έκδοση 2020-09-01
    Λήψη πλήρους κειμένου
    Άρθρο
  10. 10
    Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis

    Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis ανά Jeffrey A. Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, Gerd R Burmester, Simon LF Walsh, Michael Kreuter, Christian Stock, Steven Sambevski, Margarida Alves, Paul Emery

    Έκδοση 2024-05-01
    Λήψη πλήρους κειμένου
    Άρθρο
  11. 11
    Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

    Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis ανά Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch

    Έκδοση 2023-12-01
    Λήψη πλήρους κειμένου
    Άρθρο
  12. 12
    Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

    Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis ανά Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch

    Έκδοση 2023-07-01
    Λήψη πλήρους κειμένου
    Άρθρο
  13. 13
    Do musculoskeletal ultrasound and magnetic resonance imaging identify synovitis and tenosynovitis at the same joints and tendons? A comparative study in early inflammatory arthritis and clinically suspect arthralgia

    Do musculoskeletal ultrasound and magnetic resonance imaging identify synovitis and tenosynovitis at the same joints and tendons? A comparative study in early inflammatory arthriti... ανά Sarah Ohrndorf, Aleid C. Boer, Debbie M. Boeters, Robin M. ten Brinck, Gerd-R. Burmester, Marion C. Kortekaas, Annette H. M. van der Helm-van Mil

    Έκδοση 2019-02-01
    Λήψη πλήρους κειμένου
    Άρθρο
  14. 14
    Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

    Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observat... ανά Rieke Alten, Gerd R. Burmester, Marco Matucci-Cerinic, Jean-Hugues Salmon, Andrew Östör, Khai Jing Ng, Jens Gerwien, Liliana Zaremba-Pechmann, Alan J. M. Brnabic, Bruno Fautrel

    Έκδοση 2023-09-01
    Λήψη πλήρους κειμένου
    Άρθρο
  15. 15
    Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

    Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes ανά Cem Gabay, Gerd R. Burmester, Vibeke Strand, Jérôme Msihid, Moshe Zilberstein, Toshio Kimura, Hubert van Hoogstraten, Susan H. Boklage, Jonathan Sadeh, Neil M. H. Graham, Anita Boyapati

    Έκδοση 2020-04-01
    Λήψη πλήρους κειμένου
    Άρθρο
  16. 16
    The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

    The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therap... ανά Rieke Alten, Gerd R. Burmester, Marco Matucci-Cerinic, Jean-Hugues Salmon, Pedro Lopez-Romero, Walid Fakhouri, Inmaculada de la Torre, Liliana Zaremba-Pechmann, Thorsten Holzkämper, Bruno Fautrel

    Έκδοση 2022-10-01
    Λήψη πλήρους κειμένου
    Άρθρο
  17. 17
    Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

    Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension ανά Gerd R Burmester, Mark C Genovese, Vibeke Strand, Gregory St John, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Susan Boklage

    Έκδοση 2019-10-01
    Λήψη πλήρους κειμένου
    Άρθρο
  18. 18
    Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis

    Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis ανά Vibeke Strand, Laure Gossec, Clare W. J. Proudfoot, Chieh-I Chen, Matthew Reaney, Sophie Guillonneau, Toshio Kimura, Janet van Adelsberg, Yong Lin, Erin K. Mangan, Hubert van Hoogstraten, Gerd R. Burmester

    Έκδοση 2018-06-01
    Λήψη πλήρους κειμένου
    Άρθρο
  19. 19
    Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

    Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis ανά Peter Nash, Atul Deodhar, Philip J Mease, Yoshiya Tanaka, Tim Shaw, Gerd R Burmester, Kevin L Winthrop, Alan D Irvine, Eduardo Mysler, Stanley B Cohen, Ana P Lacerda, John Liu, Hannah Palac, Emma Guttman‑Yassky

    Έκδοση 2023-02-01
    Λήψη πλήρους κειμένου
    Άρθρο
  20. 20
    Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study

    Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study ανά Bernard G. Combe, Yoshiya Tanaka, Maya H. Buch, Peter Nash, Gerd R. Burmester, Alan J. Kivitz, Beatrix Bartok, Alena Pechonkina, Katrina Xia, Kahaku Emoto, Shungo Kano, Thijs K. Hendrikx, Robert B. M. Landewé, Daniel Aletaha

    Έκδοση 2023-01-01
    Λήψη πλήρους κειμένου
    Άρθρο

Εργαλεία αναζήτησης: